KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Acquisitions & Divestments (2023 - 2025)

Staar Surgical (STAA) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with -$74.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 298.13% year-over-year to -$74.2 million, compared with a TTM value of $3.4 million through Jan 2026, down 92.17%, and an annual FY2026 reading of $3.4 million, down 92.17% over the prior year.
  • Change in Acquisitions & Divestments was -$74.2 million for Q3 2025 at Staar Surgical, down from $26.4 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $51.1 million in Q1 2025 and bottomed at -$118.1 million in Q4 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $4.3 million, with a median of $26.4 million recorded in 2025.
  • Peak annual rise in Change in Acquisitions & Divestments hit 234.15% in 2025, while the deepest fall reached 298.13% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at -$118.1 million in 2023, then soared by 104.08% to $4.8 million in 2024, then plummeted by 1641.63% to -$74.2 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for STAA at -$74.2 million in Q3 2025, $26.4 million in Q2 2025, and $51.1 million in Q1 2025.